Showing results (81-90 of 103) with videos related to
Sort By:
Pageof 11
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2022
Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational studyMajdi Imterat, Nicolò Bizzarri, Robert Fruscio, et al.Breast Cancer Research : BCR|December 13, 2019
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapyBruno Valentin Sinn, Karsten E Weber, Wolfgang Daniel Schmitt, et al.BMC Cancer|October 4, 2022
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapyJonas Leichsenring, Valentina Vladimirova, Christine Solbach, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis of the GeparTrio trial dataSerban Dan Costa, Sibylle Loibl, Manfred Kaufmann, et al.Gynecologic Oncology|July 1, 2025
NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancerKristina Lindemann, Dominique Berton, Jalid Sehouli, et al.Plos One|February 7, 2022
Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancerFlorian Heitz, Sotirios Lakis, Philipp Harter, et al.Gynecologic Oncology|February 4, 2022
Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 studyFabian Trillsch, Sven Mahner, Beyhan Ataseven, et al.The New England Journal of Medicine|December 12, 2024
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA TrialToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.Breast Cancer Research and Treatment|May 9, 2019
Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trialCarsten Denkert, Jan Budczies, Meredith M Regan, et al.European Journal of Cancer (Oxford, England : 1990)|October 27, 2023
Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological imagesFrederik Marmé, Eva Krieghoff-Henning, Bernd Gerber, et al.Pageof 11